Sir,
We read the recent study by Newton et al (2005) with great interest. Presently, we offer a few thoughts on what their results suggest about the role of BK virus in cancer.
First, haemorrhagic cystitis and BK nephropathy in transplant patients are the principal disease entities for which BK virus has been implicated (Hirsch, 2005). We ask, how do the antibody titers of the cancer patients and controls compare to transplant patients diagnosed with BK nephropathy or haemorrhagic cystitis? It would be informative to know whether antibody titers in patients with active BK nephropathy are within the range reported for patients with carcinoma.
Similarly, how do antibody titers in BK nephropathy patients change with treatment and resolution of BK infection? Perhaps antibody titers decline following resolution of the active BK infection to levels comparable to those reported by Newton et al (2005). Consider a cancer patient with a history of prior BK infection whose antibody titers were previously high, but now have declined. In such an instance, BK virus may be implicated in carcinogenesis, although the antibody titers at the time of this study have returned to the range of normal individuals. Certainly, a study documenting how antibody titers in patients with BK nephropathy change over time would be enlightening.
Infection with polyomavirus (PV) may both disrupt the function of tumour-suppressor proteins p53 and pRb (Reich and Levine, 1982; DeCaprio et al, 1988; Bollag et al, 1989; Dyson et al, 1990; Harris et al, 1998; Pipas and Levine, 2001). As the PV infection is cleared, the ability of the cell to respond appropriately to DNA damage may remain impaired. The cells are then transformed, although the active phase of infection has resolved. We suggest, based on this ‘hit-and-run’ mechanism, that the absence of elevated titers does not exclude a role for BK virus in carcinogenesis.
Nonetheless, the ‘hit-and-run’ mechanism is difficult to defend experimentally. How does one find evidence for an infection that has resolved? We anticipate that this may become an area of active research in the near future.
Finally, Weinreb et al (2006) identified a population of patients with PV-infected ‘decoy’ cells seen on urine cytologic analysis. The incidence of bladder carcinoma in this population was significantly higher than in patients receiving urine cytologic analysis but lacking any such infected cells. Their data suggests an association of PV infection with bladder carcinoma. Did any patients in Dr Newton's study have urine cytologic analyses revealing such ‘decoy’ cells? Is there any correlation between the presence of such virally infected cells and antibody titers? The detection of ‘decoy’ cells may be more closely associated with carcinoma than antibody titers.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bollag B, Chuke WF, Frisque RJ (1989) Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J Virol 63 (2): 863–872
DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54 (2): 275–283
Dyson N, Bernards R, Friend SH, Gooding LR, Hassell JA, Major EO, Pipas JM, Vandyke T, Harlow E (1990) Large T-antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol 64: 1353–1356
Harris KF, Chang E, Christensen JB, Imperiale MJ (1998) BK virus as a potential co-factor in human cancer. Dev Biol Stand 94: 81–91
Hirsch HH (2005) BK virus: opportunity makes a pathogen. Clin Infect Dis 41 (3): 354–360
Newton R, Ribeiro T, Casabonne D, Alvarez E, Touze A, Key T, Coursaget P (2005) Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort. Br J Cancer 28l93 (11): 1305–1306
Pipas JM, Levine AJ (2001) Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 11 (1): 23–30
Reich NC, Levine AJ (1982) Specific interaction of the SV40T antigen-cellular p53 protein complex with SV40 DNA. Virology 117 (1): 286–290
Weinreb DB, Desman GT, Amolat-Apiado MJM, Godbold J, Burstein DE, Johnson EM (2006) Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 34 (3): 201–203
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Weinreb, D. BK virus and carcinoma of the prostate, kidney and bladder. Br J Cancer 94, 1948 (2006). https://doi.org/10.1038/sj.bjc.6603124
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6603124